These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17059170)

  • 21. Relative contributions of the five major human cytochromes P450, 1A2, 2C9, 2C19, 2D6, and 3A4, to the hepatic metabolism of the proteasome inhibitor bortezomib.
    Uttamsingh V; Lu C; Miwa G; Gan LS
    Drug Metab Dispos; 2005 Nov; 33(11):1723-8. PubMed ID: 16103134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Roles of CYP3A4 and CYP2C19 in methyl hydroxylated and N-oxidized metabolite formation from voriconazole, a new anti-fungal agent, in human liver microsomes.
    Murayama N; Imai N; Nakane T; Shimizu M; Yamazaki H
    Biochem Pharmacol; 2007 Jun; 73(12):2020-6. PubMed ID: 17433262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development.
    Zhou SF; Zhou ZW; Yang LP; Cai JP
    Curr Med Chem; 2009; 16(27):3480-675. PubMed ID: 19515014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of CYP2C in the in vitro bioactivation of the contraceptive steroid desogestrel.
    Gentile DM; Verhoeven CH; Shimada T; Back DJ
    J Pharmacol Exp Ther; 1998 Dec; 287(3):975-82. PubMed ID: 9864282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The inhibitory effect of polyunsaturated fatty acids on human CYP enzymes.
    Yao HT; Chang YW; Lan SJ; Chen CT; Hsu JT; Yeh TK
    Life Sci; 2006 Nov; 79(26):2432-40. PubMed ID: 16978661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro metabolism of the calmodulin antagonist DY-9760e (3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate) by human liver microsomes: involvement of cytochromes p450 in atypical kinetics and potential drug interactions.
    Tachibana S; Fujimaki Y; Yokoyama H; Okazaki O; Sudo K
    Drug Metab Dispos; 2005 Nov; 33(11):1628-36. PubMed ID: 16049129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitory effects of phthalimide derivatives on the activity of the hepatic cytochrome P450 monooxygenases CYP2C9 and CYP2C19.
    Kolukisaoglu Ü; Wendler C; Goerdes D; Diener A; Thurow K
    J Enzyme Inhib Med Chem; 2010 Dec; 25(6):876-86. PubMed ID: 20578979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of cytochromes P450 2C9 and 3A4 as the major catalysts of phenprocoumon hydroxylation in vitro.
    Ufer M; Svensson JO; Krausz KW; Gelboin HV; Rane A; Tybring G
    Eur J Clin Pharmacol; 2004 May; 60(3):173-82. PubMed ID: 15054565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic polymorphisms of CYP2C9 and CYP2C19 in the Beninese and Belgian populations.
    Allabi AC; Gala JL; Desager JP; Heusterspreute M; Horsmans Y
    Br J Clin Pharmacol; 2003 Dec; 56(6):653-7. PubMed ID: 14616425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural diversity of human xenobiotic-metabolizing cytochrome P450 monooxygenases.
    Johnson EF; Stout CD
    Biochem Biophys Res Commun; 2005 Dec; 338(1):331-6. PubMed ID: 16157296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro interaction of the antipsychotic agent olanzapine with human cytochromes P450 CYP2C9, CYP2C19, CYP2D6 and CYP3A.
    Ring BJ; Binkley SN; Vandenbranden M; Wrighton SA
    Br J Clin Pharmacol; 1996 Mar; 41(3):181-6. PubMed ID: 8866916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydrogen bonding in human p450-substrate interactions: a major contribution to binding affinity.
    Lewis DF
    ScientificWorldJournal; 2004 Dec; 4():1074-82. PubMed ID: 15632987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro evaluation of valproic acid as an inhibitor of human cytochrome P450 isoforms: preferential inhibition of cytochrome P450 2C9 (CYP2C9).
    Wen X; Wang JS; Kivistö KT; Neuvonen PJ; Backman JT
    Br J Clin Pharmacol; 2001 Nov; 52(5):547-53. PubMed ID: 11736863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoclonal antibodies specific and inhibitory to human cytochromes P450 2C8, 2C9, and 2C19.
    Krausz KW; Goldfarb I; Buters JT; Yang TJ; Gonzalez FJ; Gelboin HV
    Drug Metab Dispos; 2001 Nov; 29(11):1410-23. PubMed ID: 11602516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New insights into the structural features and functional relevance of human cytochrome P450 2C9. Part I.
    Mo SL; Zhou ZW; Yang LP; Wei MQ; Zhou SF
    Curr Drug Metab; 2009 Dec; 10(10):1075-126. PubMed ID: 20167001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Automated assessment of time-dependent inhibition of human cytochrome P450 enzymes using liquid chromatography-tandem mass spectrometry analysis.
    Atkinson A; Kenny JR; Grime K
    Drug Metab Dispos; 2005 Nov; 33(11):1637-47. PubMed ID: 16049126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular modeling of two CYP2C19 SNPs and its implications for personalized drug design.
    Wang JF; Wei DQ; Chen C; Li Y; Chou KC
    Protein Pept Lett; 2008; 15(1):27-32. PubMed ID: 18221009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative structure-activity relationships (QSARs) within cytochromes P450 2B (CYP2B) subfamily enzymes: the importance of lipophilicity for binding and metabolism.
    Lewis DF; Lake BG; Ito Y; Anzenbacher P
    Drug Metabol Drug Interact; 2006; 21(3-4):213-31. PubMed ID: 16841514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of delavirdine with human liver microsomal cytochrome P450: inhibition of CYP2C9, CYP2C19, and CYP2D6.
    Voorman RL; Payne NA; Wienkers LC; Hauer MJ; Sanders PE
    Drug Metab Dispos; 2001 Jan; 29(1):41-7. PubMed ID: 11124228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human cytochrome P450-catalyzed conversion of the proestrogenic pesticide methoxychlor into an estrogen. Role of CYP2C19 and CYP1A2 in O-demethylation.
    Stresser DM; Kupfer D
    Drug Metab Dispos; 1998 Sep; 26(9):868-74. PubMed ID: 9733665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.